Login
Navigate Fool.com
Will HSP beat
the market?

Hospira, Inc.

NYSE: HSP

Community Rating: 3 Stars: Appealing

43.43 0.50 (1.16%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $43.09
Previous Close $42.93
Daily Range $42.16 - $43.51
52-Week Range $30.86 - $45.24
Market Cap $7.2B
P/E Ratio -858.60
Dividend (Yield) $0.00 (0.0%)
Volume 1,261,545
Average Daily Volume 1,271,771
Current FY EPS $2.13

How do you think HSP
will perform against the market?

Top HSP Bull/Bear Pitches

 

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches here!

 

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches here!

News & Commentary

Why McDermott International, Medicines Co., and Liquidity Services Tumbled Today

Despite a solid beginning of the second quarter for the broader market, these three stocks gave up a lot of ground on Tuesday. Find out why here.

Top Health Care Stories: The Medicines Company, Eli Lilly, and GlaxoSmithKline

MannKind, The Medicines Company, Eli Lilly, and GlaxoSmithKline could all make health care headlines this morning.

Hospira agrees to $60 mln settlement over quality control problems

HSP Makes Notable Cross Below Critical Moving Average

Ten Top Biotech Merger and Partnership Candidates

The Growth Driver Johnson & Johnson Investors Need to Watch

A slate of recent wins suggest Johnson's (JNJ) pharmaceutical division remains one of the best in the business.

3 Big Battles in Biosimilars to Watch

The global biosimilars market is forecast to grow to $24 billion by 2019. A few major contenders -- Hospira, Novartis, and Mylan -- could profit from that growth.

Even With Growth Opportunities Ahead, Is Hospira Overvalued?

Hospira's businesses are fundamentally attractive, but the valuation seems to reflect that.

Novartis Vs. Everyone: Biologic Knockoffs

Amdocs Moves Up In Market Cap Rank, Passing Hospira

See More HSP News...

Sector

Healthcare

Industry

Drugs

Hospira, Inc. (HSP) Description

A specialty pharmaceutical and medication delivery company that is focused on products that improve the productivity, safety and efficacy of patient care. Website: http://www.hospira.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks